Table 2 Univariate and multivariate analyses for 5-year overall survival and 5-year disease-free survival in SACC patients
| Â | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
P | Regression coefficient (SE) | P | Relative risk (95% CI) | |
Overall survival | Â | Â | Â | |
Clinical stage | 0.02 | −2.025 (1.025) | 0.004 | 0.043 (0.005-0.367) |
Expression of MTUS1 | 0.035 | −1.653 (0.851) | 0.019 | 29.7 (1.735-511.62) |
T classification | 0.038 | −1.827 (1.075) | - | - |
LN classification | 0.733 | 0.376 (1.103) | - | - |
Histological grading | 0.033 | 1.344 (0.629) | 0.017 | 5.416 (1.360-21.570) |
Distant metastasis | 0.002 | 2.498 (0.817) | 0.003 | 26.09 (2.964-37.36) |
Recurrence | 0.851 | 0.158 (0.841) | - | - |
Age | 0.134 | 4.397 (2.934) | - | - |
Gender | 0.386 | −0.716 (0.826) | - | - |
Disease-free survival | Â | Â | Â | Â |
Clinical stage | 0.015 | −1.256 (0.517) | 0.94 | 0.92 (0.104-8.162) |
Expression of MTUS1 | 0.004 | −1.439 (0.506) | 0.004 | 0.255 (0.31-2.099) |
T classification | 0.059 | −0.974 (0.516) | - | - |
LN classification | 0.261 | −1.152 (1.025) | - | - |
Histological grading | 0.291 | 2.520 (0.239) | - | - |
Distant metastasis | 0.523 | 0.362 (0.567) | - | - |
Recurrence | 0.489 | −0.433 (0.626) | - | - |
Age | 0.573 | −0.250 (0.443) | - | - |
Gender | 0.707 | −0.174 (0.464) | - | - |